ANIK

Elite Trades From Anywhere Elite Trades All Summer

$100 Off Your First Year Get Elite For Just $199.50

Days

Hours

Mins

Sec

Claim Now

Peers: LFCR TKNO OGI ACB EBS PCRX HROW EOLS ANIP INDV

| Held by: VTI IWM VXF IWN AVUV SCHA VTWO DFSV DFMC DFAS

Scroll to Statements

Index	RUT
Market Cap	204.37M
Enterprise Value	189.09M
Income	-11.06M
Sales	116.26M
Book/sh	10.02
Cash/sh	3.08
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	235
IPO	May 03, 1993

P/E	-
Forward P/E	99.10
PEG	1.21
P/S	1.76
P/B	1.53
P/C	4.98
P/FCF	196.51
EV/EBITDA	-
EV/Sales	1.63
Quick Ratio	3.37
Current Ratio	4.46
Debt/Eq	0.19
LT Debt/Eq	0.18
Option/Short	Yes / Yes

EPS (ttm)	-0.79
EPS next Y	0.15
EPS next Q	-0.08
EPS this Y	-209.09%
EPS next Y	229.17%
EPS next 5Y	81.71%
EPS past 3/5Y	9.40% 14.76%
Sales past 3/5Y	-10.28% -2.86%
EPS Y/Y TTM	79.57%
Sales Y/Y TTM	-15.41%
EPS Q/Q	-9.65%
Sales Q/Q	13.16%
Earnings	Apr 29 BMO
EPS/Sales Surpr.	485.71% 5.22%

Insider Own	6.31%
Insider Trans	2.09%
Inst Own	93.12%
Inst Trans	0.49%
ROA	-5.99%
ROE	-7.85%
ROIC	-7.02%
Gross Margin	58.59%
Oper. Margin	-10.54%
Profit Margin	-9.52%
SMA20	4.56%
SMA50	4.19%
SMA200	29.63%
Trades

Shs Outstand	13.36M
Shs Float	12.47M
Short Float	3.41%
Short Ratio	4.39
Short Interest	0.43M
52W High	16.24 -5.42%
52W Low	7.87 95.17%
Volatility	3.17% 3.36%
ATR (14)	0.53
RSI (14)	59.25
Beta	0.23
Rel Volume	0.45
Avg Volume	96.85K
Volume	43,247

Perf Week	5.06%
Perf Month	6.82%
Perf Quarter	2.54%
Perf Half Y	60.84%
Perf YTD	59.83%
Perf Year	36.53%
Perf 3Y	-40.88%
Perf 5Y	-65.23%
Perf 10Y	-71.69%
Recom	1.00
Target Price	17.50
Prev Close	15.18
Price	15.36
Change	1.19%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-17-25	Initiated	B. Riley Securities	Buy	$21
Nov-01-24	Reiterated	Barrington Research	Outperform	$37 → $25
Aug-14-23	Upgrade	Barrington Research	Mkt Perform → Outperform	$24
Mar-07-23	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-09-22	Upgrade	Barrington Research	Mkt Perform → Outperform	$31
Oct-14-22	Resumed	Stephens	Equal-Weight	$26
Mar-09-22	Downgrade	Stephens	Overweight → Equal-Weight	$35
Mar-09-22	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-16-21	Initiated	Stephens	Overweight	$55
Jul-16-21	Initiated	UBS	Neutral	$46
Dec-16-20	Upgrade	Barrington Research	Mkt Perform → Outperform	$43
May-08-20	Downgrade	Barrington Research	Outperform → Mkt Perform
Jan-21-20	Upgrade	Sidoti	Neutral → Buy	$61
Jan-10-20	Upgrade	First Analysis Sec	Outperform → Strong Buy	$65
Nov-05-19	Initiated	BWS Financial	Sell	$29
Sep-24-19	Reiterated	Barrington Research	Outperform	$49 → $58
Sep-23-19	Downgrade	First Analysis Sec	Strong Buy → Outperform	$54
Jul-25-19	Upgrade	First Analysis Sec	Neutral → Strong Buy	$37 → $54
Feb-22-19	Downgrade	Sidoti	Buy → Neutral	$56 → $41
Feb-22-19	Downgrade	First Analysis Sec	Outperform → Neutral	$41 → $37

Show Previous Ratings

Jun-05-26 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-29-26 12:50PM	Anika Therapeutics, Inc. Q1 2026 Earnings Call Summary (Moby) -18.81%
07:14AM	Anika: Q1 Earnings Snapshot (Associated Press)
07:05AM	Anika Reports First Quarter 2026 Financial Results (GlobeNewswire)
Apr-15-26 04:01PM	Anika to Issue First Quarter 2026 Financial Results on Wednesday, April 29, 2026 (GlobeNewswire)
03:35PM	Loading…
Apr-07-26 03:35PM	Revance CEO Nadeem Moiz on Expansion, Opportunities & Capitalization (Exec Edge)
Apr-03-26 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Mar-03-26 03:29AM	Anika Therapeutics Touts $3B TAM, Cingal & Hyalofast Growth Plans at Canaccord MSK Conference (MarketBeat)
Feb-27-26 08:30AM	Anika Therapeutics, Inc. Q4 2025 Earnings Call Summary (Moby) +12.28%
Feb-26-26 04:09PM	Anika Therapeutics Inc (ANIK) Q4 2025 Earnings Call Highlights: Strong International Growth and ... (GuruFocus.com) +16.91%
12:15PM	Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates (Zacks)
10:59AM	Anika Therapeutics Q4 Earnings Call Highlights (MarketBeat)
07:35AM	Anika: Q4 Earnings Snapshot (Associated Press Finance)
07:05AM	Anika Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Feb-18-26 04:01PM	Anika To Present at the Canaccord Genuity 2026 Musculoskeletal Conference (GlobeNewswire)
04:01PM	Loading…
Feb-12-26 04:01PM	Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026 (GlobeNewswire)
Jan-08-26 07:00AM	Anika Therapeutics Announces Leadership Transition (GlobeNewswire)
Nov-06-25 06:00PM	Anika Therapeutics Inc (ANIK) Q3 2025 Earnings Call Highlights: Strong Growth in Regenerative ... (GuruFocus.com)
Nov-05-25 08:25AM	Anika Therapeutics (ANIK) Q3 Earnings and Revenues Top Estimates (Zacks)
07:22AM	Anika: Q3 Earnings Snapshot (Associated Press Finance)
07:05AM	Anika Reports Third Quarter 2025 Financial Results (GlobeNewswire)
07:00AM	Anika Therapeutics Reports Filing of Final PMA Module for Hyalofast Cartilage Repair Scaffold and Data from U.S. Pivotal FastTRACK Phase III Study (GlobeNewswire)
Nov-04-25 08:43AM	Anika Therapeutics Inc (ANIK) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-23-25 04:01PM	Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025 (GlobeNewswire)
Sep-19-25 06:50AM	Arcturus Therapeutics (ARCT) Surges 8.7%: Is This an Indication of Further Gains? (Zacks)
Sep-05-25 05:00AM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-29-25 09:55AM	Wall Street Analysts See a 98.59% Upside in Anika (ANIK): Can the Stock Really Move This High? (Zacks)
Aug-20-25 12:00PM	Anika (ANIK) Upgraded to Buy: Here's What You Should Know (Zacks)
Jul-30-25 08:15AM	Anika Therapeutics (ANIK) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -27.42%
07:21AM	Anika: Q2 Earnings Snapshot (Associated Press Finance)
07:05AM	Loading…
07:05AM	Anika Reports Second Quarter 2025 Financial Results (GlobeNewswire)
07:00AM	Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast Cartilage Repair Scaffold and Provides Program Update (GlobeNewswire)
Jul-29-25 10:04AM	Anika Therapeutics Inc (ANIK) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
08:15AM	uniQure (QURE) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
Jul-21-25 10:11AM	Recursion Pharmaceuticals (RXRX) Soars 5.8%: Is Further Upside Left in the Stock? (Zacks)
Jul-16-25 04:01PM	Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025 (GlobeNewswire)
Jul-03-25 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-05-25 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-20-25 08:00AM	Sidoti Events, LLC's Virtual May Micro-Cap Conference (ACCESSWIRE)
May-12-25 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
09:29AM	Company News for May 12, 2025 (Zacks)
May-10-25 03:04AM	Anika Therapeutics Inc (ANIK) Q1 2025 Earnings Call Highlights: Strategic Growth Amidst Revenue ... (GuruFocus.com)
May-09-25 08:35AM	Anika Therapeutics (ANIK) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -21.03%
07:44AM	Anika Therapeutics Posts Wider Loss From Cont. Ops. In Q1 (RTT News)
07:28AM	Anika: Q1 Earnings Snapshot (Associated Press Finance)
07:05AM	Anika Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-08-25 09:45AM	Earnings To Watch: Anika Therapeutics Inc (ANIK) Reports Q1 2025 Result (GuruFocus.com)
09:05AM	Vericel Corporation (VCEL) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-07-25 04:01PM	Anika to Participate in the Sidoti Virtual Investor Conference (GlobeNewswire)
May-05-25 09:28AM	Is the Options Market Predicting a Spike in Anika Therapeutics Stock? (Zacks)
Apr-25-25 09:00AM	Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025 (GlobeNewswire)
Apr-07-25 05:00PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.60%
Apr-03-25 08:44AM	Are Options Traders Betting on a Big Move in Anika Therapeutics (ANIK) Stock? (Zacks)
Mar-13-25 06:43AM	Q4 2024 Anika Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) -11.10%
03:09AM	Anika Therapeutics Inc (ANIK) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com)
Mar-12-25 05:25PM	Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:33PM	Anika: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Anika Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-07-25 06:00AM	Anika Completes Divestiture of Parcus Medical (GlobeNewswire)
Mar-01-25 06:42AM	Is Anika Therapeutics, Inc. (ANIK) the Best Small Cap Pharma Stocks to Buy Now? (Insider Monkey)
Feb-26-25 08:00AM	Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025 (GlobeNewswire)
Feb-25-25 08:00AM	Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference (GlobeNewswire)
Dec-23-24 04:01PM	Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-03-24 08:30AM	Sidoti Events, LLC's Virtual December Small-Cap Conference (ACCESS Newswire)
Nov-22-24 04:16PM	Anika To Participate in December 2024 Investor Conferences (GlobeNewswire)
Nov-01-24 03:07AM	Anika Therapeutics Inc (ANIK) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... (GuruFocus.com)
Oct-31-24 11:00AM	Arthrosurface Returns to it Roots Following Divestiture from Anika Therapeutics (PR Newswire) -30.67%
08:25AM	Anika Therapeutics (ANIK) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:18AM	Anika: Q3 Earnings Snapshot (Associated Press Finance)
07:05AM	Anika Reports Third Quarter 2024 Financial Results (GlobeNewswire)
07:00AM	Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical (GlobeNewswire)
Oct-30-24 09:19AM	Anika Therapeutics Inc (ANIK) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-17-24 04:01PM	Anika Announces Third Quarter 2024 Results Conference Call Date (GlobeNewswire)
Oct-09-24 06:04PM	Anika Therapeutics Inc (ANIK) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges ... (GuruFocus.com)
Oct-04-24 04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-09-24 04:45PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-15-24 04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-09-24 07:41AM	Anika Therapeutics, Inc. (ANIK): Are Hedge Funds Bullish on This Caligan Partners-Approved Stock? (Insider Monkey)
Aug-08-24 06:35PM	Anika Therapeutics (ANIK) Q2 Earnings Lag Estimates (Zacks)
05:27PM	Anika: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Anika Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-05-24 04:01PM	Anika to Participate in the Sidoti Virtual Investor Conference (GlobeNewswire)
Jul-25-24 09:00AM	Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024 (GlobeNewswire)
Jul-16-24 07:19AM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jul-11-24 08:30AM	Anika Announces Full Market Release of the Integrity Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs (GlobeNewswire)
Jul-01-24 10:35AM	Orthopedic Regenerative Surgical Products Market Size to Reach USD 6.6 Billion By 2033, at 4.4 CAGR: Insights by Dimension Market Research (GlobeNewswire)
Jun-07-24 04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-28-24 04:05PM	Anika Enters into Cooperation Agreement with Caligan Partners (GlobeNewswire)
May-09-24 12:22PM	Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2024 Earnings Call Transcript (Insider Monkey) -11.28%
10:59AM	Q1 2024 Anika Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
04:07AM	Anika Therapeutics Inc (ANIK) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ... (GuruFocus.com)
May-08-24 08:57PM	ANIK Stock Earnings: Anika Therapeutics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:40PM	Anika: Q1 Earnings Snapshot (Associated Press Finance)
04:08PM	Anika Announces CFO Transition (GlobeNewswire)
04:05PM	Anika Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-03-24 04:01PM	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-18-24 04:01PM	Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024 (GlobeNewswire)
Apr-02-24 08:00AM	Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-16-24 03:15PM	Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-14-24 08:18AM	Q4 2023 Anika Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

Executive ChairDr. Cheryl Renee Blanchard Ph.D.

PresidentMr. Stephen D. Griffin

Senior VPMr. Ian W. McLeod

Executive Director of Corporate Development & Investor RelationsMr. Matthew Hall

Senior VP of International Sales & MarketingMr. James Chase

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
HENNEMAN JOHN B III	Director	May 01 '26	Buy	14.66	5,000	73,320	54,871	May 04 08:34 AM
Griffin Stephen D.	President and CEO	Apr 30 '26	Buy	12.29	12,200	149,881	36,163	Apr 30 05:22 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

$100 Off Your First Year Get Elite For Just $199.50

Anika Therapeutics Inc

Upgrade your Finviz experience